EW
NYSEEdwards Lifesciences Corp
Health Care, Health Care Equipment
$89.72
close 7 Aug 2026
+14.79%
52-week change
$51.73B
market cap
$72.30
$96.29
52-week range
Expected price
Expected price
$56.26 – $68.76
Current price
$89.72
Signal
Could be overvalued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
P/E (TTM)51.56x
P/S (TTM)7.94x
P/B4.87x
EV/EBITDA (TTM)30.61x
FCF yield (TTM)2.77%
PEG (TTM, GAAP)—
Context
P/E, own 5-year average33.11x
P/E, sector median29.65x*
Price at 5-year median P/E$62.86*
Forward — analyst consensus
Forward P/E (FY2026)29.92x*
Forward P/E (FY2027)26.58x
Forward PEG2.38*
Consensus EPS FY2026 (28 analysts)$3.00
EPS growth (FY2026→FY2027)12.58%
Revenue growth (FY2026)11.40%
Street view
Price target (mean)$100.96*
Target upside12.53%
Ratings (buy / hold / sell)21 / 7 / 0
FY2026 EPS revisions, 30d (up / down)5 / 11
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
period to 30 Jun 2026, filed 4 Aug 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
5Y CAGR +15.58%10Y CAGR +11.56%
Assumptions
As filed — not assumptions
Current price$89.72
Cash & equivalents$2.91B
Total debt$598.70M
Shares outstanding576.60M
Result
DCF price per share$132.10
Current price$89.72
Margin of safety+47.24%
PV of years 1–10$21.22B
PV of terminal value$52.65B
Equity value$76.17B
Market-implied growth+10.38%
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $1.66B | $1.92B | $2.21B | $2.56B | $2.96B | $3.42B | $3.95B | $4.57B | $5.28B | $6.10B | $113.66B |
| PV | $1.53B | $1.64B | $1.76B | $1.88B | $2.01B | $2.15B | $2.30B | $2.47B | $2.64B | $2.82B | $52.65B |
period to 30 Jun 2026, filed 4 Aug 2026, close 7 Aug 2026